Please use this identifier to cite or link to this item:
Title: Biocompatible Catanionic Vesicles from Arginine-Based Surfactants: A New Strategy to Tune the Antimicrobial Activity and Cytotoxicity of Vesicular Systems
Author: Pinazo Gassol, Aurora
Pons Pons, Ramon
Marqués Villavecchia, Ana M.
Farfán Sellarés, Maribel
Silva, Anderson da
Pérez Muñoz, Lourdes
Keywords: Aminoàcids
Agents tensioactius
Microbiologia farmacèutica
Amino acids
Surface active agents
Pharmaceutical microbiology
Issue Date: 1-Sep-2020
Publisher: MDPI
Abstract: Their stability and low cost make catanionic vesicles suitable for application as drug delivery systems. In this work we prepared catanionic vesicles using biocompatible surfactants: two cationic arginine-based surfactants (the monocatenary Nα-lauroyl-arginine methyl ester LAM and the gemini Nα,Nϖ-bis(Nα-lauroylarginine) α, ϖ-propylendiamide C3(CA)2) and three anionic amphiphiles (the single chain sodium dodecanoate, sodium myristate, and the double chain 8-SH). The critical aggregation concentration, colloidal stability, size, and charge density of these systems were comprehensively studied for the first time. These catanionic vesicles, which form spontaneously after mixing two aqueous solutions of oppositely charged surfactants, exhibited a monodisperse population of medium-size aggregates and good stability. The antimicrobial and hemolytic activity of the vesicles can be modulated by changing the cationic/anionic surfactant ratio. Vesicles with a positive charge efficiently killed Gram-negative and Gram-positive bacteria as well as yeasts; the antibacterial activity declined with the decrease of the cationic charge density. The catanionic systems also effectively eradicated MRSA (Methicillin-resistant Staphylococcus Aureus) and Pseudomonas aeruginosa biofilms. Interestingly, the incorporation of cholesterol in the catanionic mixtures improved the stability of these colloidal systems and considerably reduced their cytotoxicity without affecting their antimicrobial activity. Additionally, these catanionic vesicles showed good DNA affinity. Their antimicrobial efficiency and low hemolytic activity render these catanionic vesicles very promising candidates for biomedical applications
Note: Reproducció del document publicat a:
It is part of: Pharmaceutics, 2020, vol. 12, num. 9
Related resource:
ISSN: 1999-4923
Appears in Collections:Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)

Files in This Item:
File Description SizeFormat 
705464.pdf4.83 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons